Arbutus Biopharma (STU:I9DN) Accounts Payable : €3.44 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Arbutus Biopharma Accounts Payable?

Arbutus Biopharma's Accounts Payable for the quarter that ended in Mar. 2024 was €3.44 Mil.

Arbutus Biopharma's quarterly Accounts Payable increased from Sep. 2023 (€2.12 Mil) to Dec. 2023 (€2.96 Mil) and increased from Dec. 2023 (€2.96 Mil) to Mar. 2024 (€3.44 Mil).

Arbutus Biopharma's annual Accounts Payable increased from Dec. 2021 (€2.81 Mil) to Dec. 2022 (€3.32 Mil) but then declined from Dec. 2022 (€3.32 Mil) to Dec. 2023 (€2.96 Mil).

Arbutus Biopharma Accounts Payable Historical Data

The historical data trend for Arbutus Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma Accounts Payable Chart

Arbutus Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

2.16

2.46

2.81

3.32

2.96

Arbutus Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															2.29	0.96	2.12	2.96	3.44

Arbutus Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Arbutus Biopharma Accounts Payable Related Terms

Thank you for viewing the detailed overview of Arbutus Biopharma's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbutus Biopharma (STU:I9DN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (STU:I9DN) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ABUS:USA

Address

701 Veterans Circle, Warminster, PA, USA, 18974

Website

http://www.arbutusbio.com

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Arbutus Biopharma (STU:I9DN) Headlines

No Headlines